Photo News

Title Co-organized 'Current Status and Strategy of Self-sufficiency of Vaccine in Korea' conference in BIO KOREA 2022
  • Writer Vital-Korea
  • Date 2022-05-17
  • View 475

VITAL-Korea and KHIDI co-organized a conference titled 'Current Status and Strategy of Self-sufficiency of Vaccine in Korea' on May 12th, 2022 in COEX, Seoul, Korea. This conference has held a session of 'BIO KOREA 2022.'

The paradigm of vaccine development is changing in the global pandemic triggered by COVID-19. Rapid vaccine development and production have become the most important issue in responding to the pandemic. As a result, the necessity of securing vaccine sovereignty is emphasized. It is impossible to control the spread of a Pandemic early with current vaccine technology, which takes more than 10 years to develop, and innovative vaccine technology is needed to respond to this. In the short term, it is necessary to expand vaccine production capacity and in the long term realize vaccine sovereignty by securing vaccine technology, such as domestic vaccine development. At this conference, experts discussed the current state of vaccine self-sufficiency and strategies in Korea. 


For more information, please click here.







Prev Organized 2021 VITAL-Korea performance sharing conference
Next Launched the Cooperative Vaccine R&D Committee